159 related articles for article (PubMed ID: 16138487)
1. Strategies for reducing the exposure to donor blood.
Murphy M
Clin Med (Lond); 2005; 5(4):337-40. PubMed ID: 16138487
[No Abstract] [Full Text] [Related]
2. Kill and cure. The hope and reality of virus inactivation.
Prowse C
Vox Sang; 1994; 67 Suppl 3():191-6. PubMed ID: 7975491
[No Abstract] [Full Text] [Related]
3. Is there a limit to the normality of blood products?
Degos L
Hematol J; 2000; 1(5):291. PubMed ID: 11920204
[No Abstract] [Full Text] [Related]
4. Bacteria and safety of the blood supply.
Kuehnert MJ; Jarvis WR
Ann Intern Med; 1998 Jul; 129(2):164-5. PubMed ID: 9669985
[No Abstract] [Full Text] [Related]
5. Safety of the blood supply.
Sloand EM; Pitt E; Klein HG
JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562
[No Abstract] [Full Text] [Related]
6. Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?
Roth WK; Seifried E
Transfusion; 2001 Jun; 41(6):845-7. PubMed ID: 11399831
[No Abstract] [Full Text] [Related]
7. The role of leukodepletion in the control of transfusion-transmitted disease.
Goldman M; Delage G
Transfus Med Rev; 1995 Jan; 9(1):9-19. PubMed ID: 7719040
[No Abstract] [Full Text] [Related]
8. [Viral safety measures of plasma for transfusion and applicability in Spain].
Pereira A
Med Clin (Barc); 2007 Oct; 129(12):458-68. PubMed ID: 17953912
[No Abstract] [Full Text] [Related]
9. Genomic screening for blood-borne viruses in transfusion settings.
Lee HH; Allain JP
Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
[No Abstract] [Full Text] [Related]
10. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.
Wagner SJ; Friedman LI; Dodd RY
Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274
[No Abstract] [Full Text] [Related]
11. Current issues in transfusion therapy. 1. Risks of infection.
Coffin CM
Postgrad Med; 1986 Dec; 80(8):219-24. PubMed ID: 3786281
[TBL] [Abstract][Full Text] [Related]
12. [Current tactics in reducing hazards of virus infection transmission during blood transfusion].
Golosova TV
Gematol Transfuziol; 1992 Mar; 37(3):35-7. PubMed ID: 1516800
[No Abstract] [Full Text] [Related]
13. Safety of the blood supply in the United States: opportunities and controversies.
AuBuchon JP; Birkmeyer JD; Busch MP
Ann Intern Med; 1997 Nov; 127(10):904-9. PubMed ID: 9382369
[TBL] [Abstract][Full Text] [Related]
14. Blood supply safety: an NHLBI perspective.
Glynn SA
Transfusion; 2008 Aug; 48(8):1541-4. PubMed ID: 18713102
[No Abstract] [Full Text] [Related]
15. [Transfusion safety and hemosurveillance].
Romeiras MC
Acta Med Port; 2000; 13(4):199-202. PubMed ID: 11155487
[TBL] [Abstract][Full Text] [Related]
16. How to limit allogenic blood transfusion in children.
Woloszczuk-Gebicka B
Paediatr Anaesth; 2005 Nov; 15(11):913-24. PubMed ID: 16238550
[No Abstract] [Full Text] [Related]
17. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia.
Kwa SB; Chen YF
Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889
[No Abstract] [Full Text] [Related]
18. [Risks to donor and recipient in blood collection and blood transfusion].
Bergmann H
Infusionsther Klin Ernahr; 1977 Apr; 4(2):84-6. PubMed ID: 558163
[TBL] [Abstract][Full Text] [Related]
19. [Transfusion-transmitted diseases].
Shimoyama R
Hokkaido Igaku Zasshi; 2008 Jan; 83(1):5-21. PubMed ID: 18283864
[TBL] [Abstract][Full Text] [Related]
20. Transfusion safety--the Ba Con Study.
Barlow JF
S D J Med; 1998 May; 51(5):151-2. PubMed ID: 9613194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
